RSSCommentary

Brain Health Executives: A Transdisciplinary Workforce Innovation—A Commentary

Brain Health Executives: A Transdisciplinary Workforce Innovation—A Commentary

| June 1, 2021

by Harris A. Eyre, MBBS (hons.), PhD; Michael Berk, MD, PhD; Erin Smith; Jeffrey Cummings, MD, ScD; and Mark Heinemeyer, MSc Dr. Eyre and Mr. Heinemeyer are co-founders of the PRODEO Institute. Dr. Eyre is with the PRODEO Institute in San Francisco, California; the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and […]

Continue Reading

Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic

Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic

| January 1, 2021

by Robert E. Litman, MD; Peter Sorantin, PhD; and Elia E. Acevedo-Diaz, MD Drs. Litman is with CBH Health, Georgetown University Medical School in Washington, DC. Dr. Sorantin is with Sorantin Outcomes, LLC, in Mountain Lakes, New Jersey. Dr. Acevedo-Diaz is with CBH Health and the National Institute of Mental Health (NIMH) in Bethesda, Maryland. […]

Continue Reading

Who Will Pay for Robotic Rehabilitation? The Growing Need for a Cost-effectiveness Analysis

Who Will Pay for Robotic Rehabilitation? The Growing Need for a Cost-effectiveness Analysis

| October 1, 2020

by Rocco Salvatore Calabrò, MD, PhD; Claudia Müller-Eising, Dr. jur.; Maria Letizia Diliberti; Alfredo Manuli, MSc; Francesca Parrinello, MD; Giuseppe Rao, MD; Vincenzo Barone, Dr. jur.; and Tamara Civello Drs. Calabrò, Manuli, Rao, Barone, Parrinello, and Ms. Civello are with IRCCS Centro Neurolesi Bonino Pulejo in Messina, Italy. Dr. Müller-Eising is with neuroneum in Bad […]

Continue Reading

Donkey Therapy and Hippotherapy: Two Faces of the Same Coin?

Donkey Therapy and Hippotherapy: Two Faces of the Same Coin?

| January 1, 2020

by Simona Portaro, MD, PhD; Giuseppa Maresca, PsyD; Antonio Raffa, MSc; Gaetano Gemelli; Barbara Aliberti; and Rocco Salvatore Calabrò, MD, PhD Dr. Portaro, Dr. Maresca, Mr. Raffa, and Dr. Calabrò are with IRCCS Centro Neurolesi “Bonino Pulejo” in Messina, Italy. Mr. Gemelli and Ms. Aliberti are with THES ASD in Milazzo, ME, Italy. FUNDING: No […]

Continue Reading

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

| July 1, 2018 | 0 Comments

By Edmund G. Howe, MD, JD; Laney Rosenzweig, MS, LMRT; and Amy Shuman, MSW, LICSW, DCSW Dr. Howe is Professor of Psychiatry and Medicine, Uniformed Services University of the Health Sciences, in Bethesda, Maryland. Ms. Rosenzweig is with the Rosenzweig Center for Rapid Recovery in Orlando, Florida. Ms. Shuman is a psychological counselor at the […]

Continue Reading

Neuroscience is the Next Oncology

Neuroscience is the Next Oncology

| April 1, 2018 | 0 Comments

by Michael D. Ehlers, MD, PhD Dr. Ehlers is with Biogen in Cambridge, Massachusetts. Innov Clin Neurosci. 2018;15(3–4):15–16 Funding: No funding was received for the preparation of this article. Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts. Prominent and expensive failures in Alzheimer’s disease therapies have led to a […]

Continue Reading

When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents

When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents

| June 1, 2017 | 0 Comments

by Muhammad Hassan Majeed, MD Dr. Majeed is an Attending Psychiatrist at Natchaug Hospital, Norwich, Connecticut. Innov Clin Neurosci. 2017;14(5–6):25–27 Funding: No funding was received for the preparation of this article. Financial Disclosures: The author has no conflicts of interest relevant to the content of this article. Keywords: Opioids, diversion, safety, confidentiality, adolescents Abstract: Patients receiving […]

Continue Reading